Upstream Bio (UPB) Cash from Operations (2023 - 2026)

Upstream Bio's Cash from Operations history runs 4 years deep, the most recent figure standing at 47852000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 16.24% year-over-year to 47852000.0; the TTM figure through Mar 2026 stood at 139962000.0 (down 69.09% YoY), while the FY2025 annual figure was 133275000.0, down 125.23% from the prior year.
• Cash from Operations for Q1 2026 stood at 47852000.0, down from 30631000.0 in the prior quarter.
• The five-year high for Cash from Operations was 8036000.0 in Q2 2024, with the low at 47852000.0 in Q1 2026.
• The 4-year median for Cash from Operations is 20926000.0 (2024), against an average of 25640900.0.
• The sharpest annual moves came in 2025 and 2026: Cash from Operations tumbled 388.29% in 2025, then fell 16.24% in 2026.
• Upstream Bio's Cash from Operations stood at 16110000.0 in 2023, then declined by 21.74% to 19612000.0 in 2024, then slumped by 56.18% to 30631000.0 in 2025, then tumbled by 56.22% to 47852000.0 in 2026.
• Business Quant data shows UPB's Cash from Operations at 47852000.0 in Q1 2026, 30631000.0 in Q4 2025, and 22240000.0 in Q3 2025.